Pharmaceutical Research and Development Increasing Efficiency through Information Technology and Externalization

GBI Research's pharma report, "PharmaceuticalScope
Research and Development (R&D) - IncreasingThe report analyses the key measures adopted to
Efficency Through Information Technology andimprove the R&D efficiency in the
Externalization" provides key data, information andpharmaceutical and biotech industry along with the
analysis on major pharmaceutical R&D practicesmajor challenges that have led to a decrease in the
at the global level in order to improve its efficiencyR&D productivity over the last decade. The
and effectiveness. This pharmaceutical and healthcarescope of the report includes:
report provides comprehensive insight into the major- Major challenges in the current pharmaceutical
challenges in the current pharmaceutical R&DR&D landscape.
landscape. It analyzes key measures and practices- Key solutions adopted by the pharmaceutical
(mergers and acquisitions, R&D restructuring,industry to improve the R&D productivity which
outsourcing and active lifecycle management)include strategic mergers and acquisitions, R&D
adopted by the pharmaceutical industry to tacklerestructuring, outsourcing and active lifecycle
these challenges and improve the R&Dmanagement.
efficiency. The report substantiates the analysis with- More than 25 examples and case studies explaining
various case studies to study the effect of measureeach solution and its impact on the R&D
post-implementation. The report also provides anproductivity in a short and long term.
analytical insight into the potential solutions that have- Qualitative analysis of the major potential solutions
tremendous potential to improve the futurethat can improve the R&D productivity in the
pharmaceutical and biotech R&D productivity.future.
The pharmaceutical industry has witnessed aReasons to buy
significant decline in R&D productivity over theThe report will enhance your decision making. It will
past few years, which has become a matter ofallow you to:
concern among the key stakeholders in the industry,- Identify the key R&D challenges in the industry
particularly the pharmaceutical companies. While theand its impact on your company's R&D
R&D expenditure of the industry has steadilyproductivity.
increased, the output has been declining. The increase- Understand the three different focus areas of
in the number of late-stage development failures isimproving R&D efficiency and select the one
costing the pharmaceutical industry dearly. In addition,best suited to the company's long term business
the stringent regulatory mechanisms on the pricingstrategy.
and reimbursement of approved drugs have added- Develop more efficient and effective solutions by
to the pressure. Pharmaceutical companies have triedidentifying the implementation issues from the case
many ways to improve the R&D efficiencystudies and examples covered for each solution.
which include the acquisitions of small biotechnology- Ensure sustainable R&D growth by identifying
and pharmaceutical companies, R&Dlong term potential solutions to improve R&D
restructuring, outsourcing and better lifecycleefficiency.
management of their existing drugs in the market.- Create an integrated and agile R&D
However, there has been limited success achieved toorganization through the understanding of key
date.technologies and other external partners in improving
This report is built using data and information sourcedthe R&D efficiency in future.
from proprietary databases, primary and secondary- Optimize R&D efforts by identifying the key
research and in house analysis by GBI Research'sareas with maximum revenue potential in future.
team of industry experts.